(Q32049879)

5 July 2017

1 reference

title

A review of budesonide inhalation suspension in the treatment of pediatric asthma (English)

1 reference

5 July 2017

1 reference

Szefler SJ

1

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

5 July 2017

1 reference

5 July 2017

volume

21

1 reference

5 July 2017

issue

2

1 reference

5 July 2017

page(s)

195-206

1 reference

The natural history of asthma.

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Effectiveness of prophylactic inhaled steroids in childhood asthma: a systemic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Treatment of childhood asthma. Options and rationale for inhaled therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Effects of regular inhalation of beclomethasone dipropionate and sodium cromoglycate on bronchial hyperreactivity in asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Long-term comparison of three combinations of albuterol, theophylline, and beclomethasone in children with chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Asthma and anaphylaxis: a relevant model for chronic disease? An historical analysis of directions in asthma research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Molecular mechanisms of glucocorticoid action in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Efficacy and safety of inhaled corticosteroids. New developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

A study of the mechanism of the antiasthmatic action of inhaled budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Systemic availability and pharmacokinetics of nebulised budesonide in preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Controlled trial of budesonide given by the nebuhaler in preschool children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Inhaled budesonide for chronic wheezing under 18 months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Establishing a therapeutic index for the inhaled corticosteroids: part II. Comparisons of systemic activity and safety among different inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Effects of inhaled corticosteroids on the consequences of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

Airways remodelling in asthma: no doubt, no more?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.195.34115

10.1592/PHCO.21.2.195.34115

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference